Recombinant Human CD20 Protein Biotinylated

<strong>Recombinant Human CD20 Protein Biotinylated</strong>_x000D_ <strong>Catalog number:</strong> B2019046_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 10 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> 23.9 kDa_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> −20°C_x000D_ <strong>Keywords:</strong> B1 Protein, Human; Bp35 Protein, Human; CD20 Protein, Human; CVID5 Protein, Human; FMC7 Protein, Human; LEU-16 Protein, Human; S7 Protein, Human_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Kubo M, Matsumoto M. Frontiers in pathophysiology and management of thrombotic thrombocytopenic purpura Int J Hematol. 2023 Mar;117(3):331-340._x000D_ 2: Nicolai CJ, Parker MH, Qin J, Tang W, Ulrich-Lewis JT, Gottschalk RJ, Cooper SE, Hernandez Lopez SA, Parrilla D, Mangio RS, Ericson NG, Brandes AH, Umuhoza S, Michels KR, McDonnell MM, Park LY, Shin S, Leung WH, Scharenberg AM, Kiem HP, Larson RP, Beitz LO, Ryu BY. In vivo CAR T-cell generation in nonhuman primates using lentiviral vectors displaying a multidomain fusion ligand Blood. 2024 Aug 29;144(9):977-987._x000D_ 3: Engelberts PJ, Hiemstra IH, de Jong B, Schuurhuis DH, Meesters J, Beltran Hernandez I, Oostindie SC, Neijssen J, van den Brink EN, Horbach GJ, Verploegen S, Labrijn AF, Salcedo T, Schuurman J, Parren PWHI, Breij ECW. DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosing EBioMedicine. 2020 Feb;52:102625._x000D_ 4: Baeuerle PA, Wesche H. T-cell-engaging antibodies for the treatment of solid tumors: challenges and opportunities Curr Opin Oncol. 2022 Sep 1;34(5):552-558._x000D_ 5: Zhang B, Brahma RK, Zhu L, Feng J, Hu S, Qian L, Du S, Yao SQ, Ge J. Insulin-like Growth Factor 2 (IGF2)-Fused Lysosomal Targeting Chimeras for Degradation of Extracellular and Membrane Proteins J Am Chem Soc. 2023 Nov 8;145(44):24272-24283._x000D_ 6: Zah E, Lin MY, Silva-Benedict A, Jensen MC, Chen YY. T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells Cancer Immunol Res. 2016 Jun;4(6):498-508._x000D_ 7: Habibi Anbouhi M, Feiz Barazandeh A, Bouzari S, Abolhassani M, Khanahmad H, Golkar M, Aghasadeghi MR, Behdani M, Jahanian-Najafabadi A, Shokrgozar MA. Functional recombinant extra membrane loop of human CD20, an alternative of the full length CD20 antigen Iran Biomed J. 2012;16(3):121-6._x000D_ 8: Trinh KR, Vasuthasawat A, Steward KK, Yamada RE, Timmerman JM, Morrison SL. Anti-CD20-interferon-β fusion protein therapy of murine B-cell lymphomas J Immunother. 2013 Jun;36(5):305-18._x000D_ 9: Hill SL, Davies A. Subcutaneous rituximab with recombinant human hyaluronidase in the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia Future Oncol. 2018 Jul;14(17):1691-1699._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/29561802">10: Haghighi M, Khanahmad H, Palizban A. Selection and Characterization of Single-Stranded DNA Aptamers Binding Human B-Cell Surface Protein CD20 by Cell-SELEX Molecules. 2018 Mar 21;23(4):715. </a>_x000D_ _x000D_ <strong>Products Related to Recombinant Human CD20 Protein Biotinylated can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>